Cleveland clinic launches massive biorepository to unlock secrets of heart disease
NCT ID NCT06560424
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study is creating a large collection of blood, urine, stool, and heart tissue samples from 10,000 people with and without heart or metabolic conditions. The goal is to store these samples along with medical information to speed up future research into what causes these diseases and how to treat them. Participants simply donate samples and allow access to their health records.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- What this could lead to
- If successful, this biorepository will provide a rich resource for future studies, potentially leading to better understanding and new treatments for heart and metabolic diseases.
- What could go wrong
- This is an observational study that does not test any treatment. It simply collects samples for future research, so there is no direct benefit to participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cleveland Clinic Main Campus
RECRUITINGCleveland, Ohio, 44195, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can better healthcare access save hearts after prison?
- Can lifestyle choices after a stroke extend life and prevent a second one?
- Could a simple health chat slash heart disease and cancer risk?
- One scan, many answers: can a new CT predict heart risks after stenting?
- Digital coaching aims to boost heart health in obesity
- Wearable sensor may replace the dreaded glucose drink test for gestational diabetes